The activation of astrocytes, characterized by cellular hypertrophy and an increase in glial fibrillary acidic protein (GFAP) expression, is a histopathological hallmark of diverse neurological disorders, including AD. The gene discussed is GFAP; the disease is Alzheimer disease.